The #PRE-EVENT for investors and startups took place on 6 March 2018, at Stavanger Forum. Among the participants were several family offices and professional investors from Oslo, Bergen, Trondheim and #Stavanger.
Susanne Stuffers, MD, PhD, Equity Research Analyst at Arctic Securities AS, gave a brilliant introduction to investing in biotech and healthcare technology companies.
Erling Nordbø, CEO of Aleap, explained how they are developing an investor network for early stage investments.
Erlend Skagseth, Managing Partner at Sarsia Seed Management, presented their portfolio.
Some selected early stage companies gave presentations and answered questions: Remote Health International AS, Anzyz Technologies AS, Som Sagt AS, bitYoga AS, iNANOD AS and MicroA.
The purpose of the Pre-Event was to focus attention on 37 °C Life Science Technology event, taking place from 19 – 20 June 2018 at the Stavanger Forum in Norway, in order to mobilize more investors into the life science space and to facilitate matchmaking between investors & companies.
Arne Hansson Rannestad, General Manager of 37 ºC #Life Science Technology #Conference & #Exhibition, briefly presented the program which was well received by the audience.